CCIA
IRWD icon

Campbell & Co Investment Adviser’s Ironwood Pharmaceuticals IRWD Stock Holding History

Campbell & Co Investment Adviser’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,708
Closed -$259K – 1183
2024
Q1 		$259K Buy
+29,708
New +$360K 0.02% 954
2023
Q3 		– Sell
-20,384
Closed -$217K – 1073
2023
Q2 		$217K Sell
20,384
-4,575
-18% -$49.2K 0.04% 781
2023
Q1 		$263K Sell
24,959
-11,368
-31% -$127K 0.05% 652
2022
Q4 		$450K Buy
36,327
+22,343
+160% +$253K 0.11% 360
2022
Q3 		$145K Sell
13,984
-29,709
-68% -$337K 0.03% 661
2022
Q2 		$504K Buy
+43,693
New +$515K 0.14% 273
2022
Q1 		– Sell
-18,816
Closed -$219K – 787
2021
Q4 		$219K Sell
18,816
-4,800
-20% -$58.9K 0.08% 504
2021
Q3 		$308K Buy
23,616
+11,450
+94% +$148K 0.1% 366
2021
Q2 		$157K Buy
+12,166
New +$139K 0.06% 478
2021
Q1 		– Sell
-12,866
Closed -$147K – 520
2020
Q4 		$147K Buy
+12,866
New +$141K 0.09% 382
2020
Q3 		– Sell
-11,676
Closed -$120K – 429
2020
Q2 		$120K Buy
+11,676
New +$120K 0.15% 255
2018
Q4 		– Sell
-16,119
Closed -$249K – 411
2018
Q3 		$249K Buy
+16,119
New +$255K 0.17% 280
2017
Q2 		– Sell
-17,173
Closed -$245K – 345
2017
Q1 		$245K Buy
+17,173
New +$235K 0.63% 74
2015
Q3 		– Sell
-41,766
Closed -$422K – 357
2015
Q2 		$422K Buy
+41,766
New +$485K 0.36% 93

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Campbell & Co Investment Adviser's IRWD Position: Q2 2024 in Review

Campbell & Co Investment Adviser sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 29,708 shares — an estimated $259K sold.

Campbell & Co Investment Adviser first reported a position in IRWD in Q2 2015 and held it in 14 quarters. The position peaked at $504K in Q2 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • Campbell & Co Investment Adviser reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 29,708 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $259K.
  • Campbell & Co Investment Adviser first reported a position in Ironwood Pharmaceuticals in Q2 2015 and held it in 14 quarters.
  • Campbell & Co Investment Adviser's Ironwood Pharmaceuticals position peaked at $504K in Q2 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2024, filed 13 Aug 2024.